Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial

This cohort study assesses the durability of protection against symptomatic COVID-19 among participants of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine trial.

Detalles Bibliográficos
Autores principales: Lin, Dan-Yu, Baden, Lindsey R., El Sahly, Hana M., Essink, Brandon, Neuzil, Kathleen M., Corey, Lawrence, Miller, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178430/
https://www.ncbi.nlm.nih.gov/pubmed/35675078
http://dx.doi.org/10.1001/jamanetworkopen.2022.15984
_version_ 1784723058753273856
author Lin, Dan-Yu
Baden, Lindsey R.
El Sahly, Hana M.
Essink, Brandon
Neuzil, Kathleen M.
Corey, Lawrence
Miller, Jacqueline
author_facet Lin, Dan-Yu
Baden, Lindsey R.
El Sahly, Hana M.
Essink, Brandon
Neuzil, Kathleen M.
Corey, Lawrence
Miller, Jacqueline
author_sort Lin, Dan-Yu
collection PubMed
description This cohort study assesses the durability of protection against symptomatic COVID-19 among participants of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine trial.
format Online
Article
Text
id pubmed-9178430
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-91784302022-06-16 Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial Lin, Dan-Yu Baden, Lindsey R. El Sahly, Hana M. Essink, Brandon Neuzil, Kathleen M. Corey, Lawrence Miller, Jacqueline JAMA Netw Open Research Letter This cohort study assesses the durability of protection against symptomatic COVID-19 among participants of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine trial. American Medical Association 2022-06-08 /pmc/articles/PMC9178430/ /pubmed/35675078 http://dx.doi.org/10.1001/jamanetworkopen.2022.15984 Text en Copyright 2022 Lin DY et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Lin, Dan-Yu
Baden, Lindsey R.
El Sahly, Hana M.
Essink, Brandon
Neuzil, Kathleen M.
Corey, Lawrence
Miller, Jacqueline
Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
title Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
title_full Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
title_fullStr Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
title_full_unstemmed Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
title_short Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial
title_sort durability of protection against symptomatic covid-19 among participants of the mrna-1273 sars-cov-2 vaccine trial
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178430/
https://www.ncbi.nlm.nih.gov/pubmed/35675078
http://dx.doi.org/10.1001/jamanetworkopen.2022.15984
work_keys_str_mv AT lindanyu durabilityofprotectionagainstsymptomaticcovid19amongparticipantsofthemrna1273sarscov2vaccinetrial
AT badenlindseyr durabilityofprotectionagainstsymptomaticcovid19amongparticipantsofthemrna1273sarscov2vaccinetrial
AT elsahlyhanam durabilityofprotectionagainstsymptomaticcovid19amongparticipantsofthemrna1273sarscov2vaccinetrial
AT essinkbrandon durabilityofprotectionagainstsymptomaticcovid19amongparticipantsofthemrna1273sarscov2vaccinetrial
AT neuzilkathleenm durabilityofprotectionagainstsymptomaticcovid19amongparticipantsofthemrna1273sarscov2vaccinetrial
AT coreylawrence durabilityofprotectionagainstsymptomaticcovid19amongparticipantsofthemrna1273sarscov2vaccinetrial
AT millerjacqueline durabilityofprotectionagainstsymptomaticcovid19amongparticipantsofthemrna1273sarscov2vaccinetrial

Ejemplares similares